From the Departments of Neurology (A.L., S.L.S., P.L.M.) and Radiology (J.B.P., J.K.-K., P.C.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Internal Medicine (E.R., D.M.M.), McGovern Medical School, University of Texas Health Science Center at Houston; Department of Neuroradiology (A.L., M.C.), Goethe University, Frankfurt am Main, Germany; andDepartment of Neurosurgery (E.S.), Boston Children's Hospital, Harvard Medical School, Boston, MA.
Neurology. 2021 Jan 26;96(4):e538-e552. doi: 10.1212/WNL.0000000000011210. Epub 2020 Nov 16.
To establish progression of imaging biomarkers of stroke, arterial steno-occlusive disease, and white matter injury in patients with smooth muscle dysfunction syndrome caused by mutations in the gene, we analyzed 113 cerebral MRI scans from a retrospective cohort of 27 patients with Arg179 pathogenic variants.
Systematic quantifications of arterial ischemic strokes and white matter lesions were performed on baseline and follow-up scans using planimetric methods. Critical stenosis and arterial vessel diameters were quantified applying manual and semiautomated methods to cerebral magnetic resonance angiograms. We then assessed correlations between arterial abnormalities and parenchymal injury.
We found characteristic patterns of acute white matter ischemic injury and progressive internal carotid artery stenosis during infancy. Longitudinal analysis of patients older than 1.2 years showed stable white matter hyperintensities but increased number of cystic-like lesions over time. Progressive narrowing of the terminal internal carotid artery occurred in 80% of patients and correlated with the number of critical stenoses in cerebral arteries and arterial ischemic infarctions. Arterial ischemic strokes occurred in same territories affected by critical stenosis.
We found characteristic, early, and progressive cerebrovascular abnormalities in patients with Arg179 pathogenic variants. Our longitudinal data suggest that while steno-occlusive disease progresses over time and is associated with arterial ischemic infarctions and cystic-like white matter lesions, white matter hyperintensities can remain stable over long periods. The evaluated metrics will enable diagnosis in early infancy and be used to monitor disease progression, guide timing of stroke preventive interventions, and assess response to current and future therapies.
为了建立因基因 突变导致平滑肌功能障碍综合征患者的中风、动脉狭窄性闭塞性疾病和白质损伤的影像学生物标志物进展,我们分析了 27 名携带 Arg179 致病性变异患者的回顾性队列中的 113 例脑 MRI 扫描。
采用平面测量法对基线和随访扫描进行动脉缺血性中风和白质病变的系统定量分析。采用手动和半自动方法对脑磁共振血管造影进行临界狭窄和动脉血管直径的定量分析。然后,我们评估了动脉异常与实质损伤之间的相关性。
我们发现了在婴儿期急性白质缺血性损伤和进行性颈内动脉狭窄的特征性模式。对年龄大于 1.2 岁的患者进行纵向分析,发现稳定的白质高信号,但随着时间的推移,囊性样病变的数量增加。80%的患者出现终末颈内动脉进行性变窄,与脑动脉和动脉性脑梗死的临界狭窄数量相关。动脉性脑梗死发生在受临界狭窄影响的相同区域。
我们发现了携带 Arg179 致病性变异的患者具有特征性、早期和进行性的脑血管异常。我们的纵向数据表明,虽然狭窄性疾病随着时间的推移而进展,并与动脉性脑梗死和囊性样白质病变相关,但白质高信号可以在很长一段时间内保持稳定。评估的指标将能够在婴儿早期进行诊断,并用于监测疾病进展、指导中风预防干预的时机,以及评估当前和未来治疗的效果。